Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114075 · ClinicalTrials.gov registry record · Phase 2
Effects of Walking Analysis on Surgical Outcomes
A Phase 2 study of Cerebral Palsy, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- Phase 2
- Development phase
- 186
- Enrollment target
- 2
- Study locations
NCT00114075: Completed Phase 2 study of Cerebral Palsy, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT00114075 is a Phase 2 study of Cerebral Palsy that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 186 participants, below the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00114075, a Phase 2 study of Cerebral Palsy, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 186 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the effects of pre-operative gait analysis testing on surgical outcomes in children with cerebral palsy who have problems walking.
Conditions Studied
Interventions
- PROCEDURE Surgery with gait analysis report
- PROCEDURE Surgery without gait analysis report
Study Locations (2)
California
- Shriners Hospital for Children, Los Angeles - Los Angeles
- Childrens Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
What the finished NCT00114075 record still lists
NCT00114075 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 2 interventions - of which Surgery with gait analysis report is the first listed.
NCT00114075 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00114075 about?
NCT00114075 is a clinical study titled "Effects of Walking Analysis on Surgical Outcomes". The purpose of this study is to evaluate the effects of pre-operative gait analysis testing on surgical outcomes in children with cerebral palsy who have problems walking.
What is the current status of trial NCT00114075?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 186 participants. The study started on 2005-01. Estimated completion is 2010-07.
What conditions does trial NCT00114075 study?
This clinical trial studies the following conditions: Cerebral Palsy.
What interventions are being tested in trial NCT00114075?
The interventions under investigation include: Surgery with gait analysis report (PROCEDURE), Surgery without gait analysis report (PROCEDURE).
Who is sponsoring clinical trial NCT00114075?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114075 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00114075's enrollment target sits among peer trials
186 12th of 91 higher than 80 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acupuncture as Complementary Therapy for Cerebral Palsy
COMPLETED · Phase 2
-
Botulinum Toxin (BOTOX) for Cerebral Palsy
COMPLETED · Phase 2
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia